Payment overview · 2025
General Payments
$46.13
3 reported records · 2 companies
Healthcare provider profile · identity verified
David Caron, MD
Allopathic & Osteopathic Physicians|Internal Medicine · GRANITE QUARRY, NC · NPI 1467518928
Verified facts
What the public records show
CMS Open Payments records show David Caron, MD received $46.13 in general payments during 2025 across 3 reported records.
Amgen Inc. accounted for 65.8% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 4 associated products.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported BEVESPI AEROSPHERE as an associated drug or biological on 763 records involving 473 distinct recipient NPIs. Public Medicare Part D data also shows 15 claims for Bevespi Aerosphere by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 33 claims for Farxiga by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYMBICORT as an associated drug or biological on 71 records involving 51 distinct recipient NPIs. Public Medicare Part D data also shows 73 claims for Symbicort by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Amgen Inc. | Unresolved — no canonical attribution shown | $30.36 | 65.8% | 2 | 2025 |
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $15.77 | 34.2% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $46.13 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| OTEZLA Normalized: otezla |
Drug | Amgen Inc. | $15.79 | 1 | 2025 |
Source payment records
|
|||||
| REPATHA Normalized: repatha |
Biological | Amgen Inc. | $15.79 | 1 | 2025 |
Source payment records
|
|||||
| AIRSUPRA Normalized: airsupra |
Drug | AstraZeneca Pharmaceuticals LP | $15.77 | 1 | 2025 |
Source payment records
|
|||||
| EVENITY Normalized: evenity |
Biological | Amgen Inc. | $14.57 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | BEVESPI AEROSPHERE open payments reported associated product |
CMS Open Payments — General Payments 763 supporting records · 473 recipient NPIs · example record 1206131384 |
Bevespi Aerosphere · 2024 Exact normalized brand match · 1 Part D row |
15 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | FARXIGA open payments reported associated product |
CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362 |
Farxiga · 2024 Exact normalized brand match · 1 Part D row |
33 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | SYMBICORT open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 51 recipient NPIs · example record 1206132610 |
Symbicort · 2024 Exact normalized brand match · 1 Part D row |
73 | 19 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 738 | 234 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 641 | 199 |
| Metformin Hcl Er | Metformin Hcl | 510 | 163 |
| Amlodipine Besylate | Amlodipine Besylate | 468 | 161 |
| Losartan Potassium | Losartan Potassium | 423 | 127 |
| Lisinopril | Lisinopril | 413 | 143 |
| Jardiance | Empagliflozin | 369 | 95 |
| Levothyroxine Sodium | Levothyroxine Sodium | 322 | 94 |
| Pantoprazole Sodium | Pantoprazole Sodium | 299 | 109 |
| Gabapentin | Gabapentin | 287 | 102 |
| Metoprolol Succinate | Metoprolol Succinate | 250 | 78 |
| Hydrochlorothiazide | Hydrochlorothiazide | 245 | 85 |
| Mounjaro | Tirzepatide | 241 | 51 |
| Omeprazole | Omeprazole | 235 | 77 |
| Clopidogrel | Clopidogrel Bisulfate | 228 | 73 |
| Tamsulosin Hcl | Tamsulosin Hcl | 226 | 72 |
| Telmisartan | Telmisartan | 208 | 57 |
| Carvedilol | Carvedilol | 201 | 63 |
| Ezetimibe | Ezetimibe | 200 | 64 |
| Famotidine | Famotidine | 194 | 75 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 191 | 76 |
| Trazodone Hcl | Trazodone Hcl | 189 | 74 |
| Montelukast Sodium | Montelukast Sodium | 188 | 65 |
| Fluticasone Propionate | Fluticasone Propionate | 178 | 78 |
| Spironolactone | Spironolactone | 172 | 60 |
| Duloxetine Hcl | Duloxetine Hcl | 170 | 57 |
| Eliquis | Apixaban | 165 | 48 |
| Glipizide Er | Glipizide | 146 | 50 |
| Allopurinol | Allopurinol | 142 | 44 |
| Tramadol Hcl | Tramadol Hcl | 136 | 38 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 121 | 23 |
| Buspirone Hcl | Buspirone Hcl | 119 | 38 |
| Tizanidine Hcl | Tizanidine Hcl | 117 | 29 |
| Prednisone | Prednisone | 114 | 76 |
| Lactulose | Lactulose | 109 | 52 |
| Escitalopram Oxalate | Escitalopram Oxalate | 108 | 34 |
| Sertraline Hcl | Sertraline Hcl | 100 | 31 |
| Finasteride | Finasteride | 94 | 36 |
| Pregabalin | Pregabalin | 93 | 32 |
| Ondansetron Hcl | Ondansetron Hcl | 92 | 42 |
| Atenolol | Atenolol | 91 | 25 |
| Pravastatin Sodium | Pravastatin Sodium | 91 | 28 |
| Torsemide | Torsemide | 89 | 28 |
| Azelastine Hcl | Azelastine Hcl | 87 | 42 |
| Ozempic | Semaglutide | 87 | 24 |
| Baclofen | Baclofen | 84 | 37 |
| Metformin Hcl | Metformin Hcl | 78 | 28 |
| Fluoxetine Hcl | Fluoxetine Hcl | 73 | 30 |
| Symbicort | Budesonide/Formoterol Fumarate | 73 | 19 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 69 | 26 |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 68 | 18 |
| Repatha Sureclick | Evolocumab | 68 | 18 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 63 | 19 |
| Doxycycline Hyclate | Doxycycline Hyclate | 62 | 52 |
| Mirtazapine | Mirtazapine | 62 | 22 |
| Meloxicam | Meloxicam | 59 | 21 |
| Simvastatin | Simvastatin | 59 | 20 |
| Donepezil Hcl | Donepezil Hcl | 57 | 17 |
| Furosemide | Furosemide | 57 | 23 |
| Mupirocin | Mupirocin | 57 | 41 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 56 | 14 |
| Bupropion Xl | Bupropion Hcl | 55 | 18 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 53 | 47 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 53 | 20 |
| Citalopram Hbr | Citalopram Hydrobromide | 52 | 17 |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 52 | 11 |
| Topiramate | Topiramate | 51 | 15 |
| Potassium Chloride | Potassium Chloride | 50 | 22 |
| Cephalexin | Cephalexin | 49 | 45 |
| Ketoconazole | Ketoconazole | 48 | 31 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 48 | 14 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 47 | 30 |
| Lamotrigine | Lamotrigine | 46 | 11 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 45 | 19 |
| Metoprolol Tartrate | Metoprolol Tartrate | 45 | 16 |
| Trulicity | Dulaglutide | 45 | 13 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 44 | 20 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 44 | 16 |
| Myrbetriq | Mirabegron | 43 | 12 |
| Promethazine Hcl | Promethazine Hcl | 42 | 14 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 41 | 16 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 41 | 15 |
| Linzess | Linaclotide | 41 | 21 |
| Nortriptyline Hcl | Nortriptyline Hcl | 41 | 17 |
| Azithromycin | Azithromycin | 39 | 30 |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 38 | 15 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 37 | 12 |
| Midodrine Hcl | Midodrine Hcl | 36 | suppressed |
| Celecoxib | Celecoxib | 35 | 17 |
| Paroxetine Hcl | Paroxetine Hcl | 35 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 35 | 11 |
| Testosterone Cypionate | Testosterone Cypionate | 35 | 13 |
| Naltrexone Hcl | Naltrexone Hcl | 34 | 13 |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 33 | 17 |
| Farxiga | Dapagliflozin Propanediol | 33 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 33 | 16 |
| Hydrocortisone | Hydrocortisone | 32 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 32 | 12 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 31 | 12 |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 31 | 16 |
| Alprazolam | Alprazolam | 30 | suppressed |
| Cilostazol | Cilostazol | 30 | 12 |
| Hydralazine Hcl | Hydralazine Hcl | 30 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 30 | suppressed |
| Nitroglycerin | Nitroglycerin | 30 | 19 |
| Spironolactone-Hctz | Spironolact/Hydrochlorothiazid | 30 | 13 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 29 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 29 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 29 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 29 | 13 |
| Chlorthalidone | Chlorthalidone | 28 | 12 |
| Sucralfate | Sucralfate | 28 | suppressed |
| Roflumilast | Roflumilast | 27 | suppressed |
| Synthroid | Levothyroxine Sodium | 27 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 26 | 11 |
| Clonidine Hcl | Clonidine Hcl | 25 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 25 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 25 | 25 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 24 | 12 |
| Digoxin | Digoxin | 24 | suppressed |
| Fluconazole | Fluconazole | 24 | 17 |
| Methotrexate | Methotrexate Sodium | 24 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 24 | 16 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 24 | suppressed |
| Risperidone | Risperidone | 23 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 23 | suppressed |
| Entresto | Sacubitril/Valsartan | 22 | suppressed |
| Irbesartan | Irbesartan | 22 | suppressed |
| Synjardy Xr | Empagliflozin/Metformin Hcl | 22 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 21 | suppressed |
| Colchicine | Colchicine | 21 | 12 |
| Ipratropium Bromide | Ipratropium Bromide | 21 | 11 |
| Morphine Sulfate | Morphine Sulfate | 21 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 21 | suppressed |
| Nystatin | Nystatin | 21 | 12 |
| Candesartan Cilexetil | Candesartan Cilexetil | 20 | suppressed |
| Ondansetron Odt | Ondansetron | 20 | suppressed |
| Valsartan | Valsartan | 20 | suppressed |
| Vraylar | Cariprazine Hcl | 20 | suppressed |
| Memantine Hcl | Memantine Hcl | 19 | suppressed |
| Ibuprofen | Ibuprofen | 18 | suppressed |
| Olanzapine | Olanzapine | 18 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 18 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 18 | suppressed |
| Temazepam | Temazepam | 18 | suppressed |
| Vascepa | Icosapent Ethyl | 18 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 17 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 16 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 15 | suppressed |
| Bevespi Aerosphere | Glycopyrrolate/Formoterol Fum | 15 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 15 | suppressed |
| Levemir Flexpen | Insulin Detemir | 15 | suppressed |
| Levetiracetam | Levetiracetam | 15 | suppressed |
| Lorazepam | Lorazepam | 15 | suppressed |
| Minocycline Hcl | Minocycline Hcl | 15 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 15 | 15 |
| Teriparatide | Teriparatide | 15 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 14 | suppressed |
| Ranolazine Er | Ranolazine | 14 | suppressed |
| Restasis | Cyclosporine | 14 | suppressed |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 13 | 13 |
| Bupropion Hcl Sr | Bupropion Hcl | 13 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 13 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 13 | suppressed |
| Kerendia | Finerenone | 13 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Mitigare | Colchicine | 13 | suppressed |
| Praluent Pen | Alirocumab | 13 | suppressed |
| Lansoprazole | Lansoprazole | 12 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 12 | suppressed |
| Nurtec Odt | Rimegepant Sulfate | 12 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 12 | suppressed |
| Omnipod 5 Dexg7g6 Pods (Gen 5) | Insulin Pump Cart,auto,bt,g6/7 | 12 | suppressed |
| Pitavastatin Calcium | Pitavastatin Calcium | 12 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 12 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 11 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 11 | suppressed |
| Cevimeline Hcl | Cevimeline Hcl | 11 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 11 | 11 |
| Diclofenac Sodium | Diclofenac Sodium | 11 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 11 | suppressed |
| Glipizide | Glipizide | 11 | suppressed |
| Januvia | Sitagliptin Phosphate | 11 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $46.13 · 3 records | Amgen Inc. | AIRSUPRA, EVENITY, OTEZLA, REPATHA | 3 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error